CARBIDOPA

CARBIDOPA was reported 47271 times

CARBIDOPA is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EXFOLIATION GLAUCOMA 2 0.0714
1 VASCULAR ENCEPHALOPATHY 17 0.0599
2 SUPINE HYPERTENSION 11 0.0582
3 AMIMIA 6 0.0545
4 DEVICE EFFECT DECREASED 2 0.0513
5 OEDEMA DUE TO CARDIAC DISEASE 6 0.0429
6 ANAL CANDIDIASIS 2 0.0345
7 DELUSION OF REPLACEMENT 3 0.0300
8 CATABOLIC STATE 2 0.0299
9 PARKINSONISM HYPERPYREXIA SYNDROME 5 0.0279
10 STOMA SITE ODOUR 6 0.0268
11 MEDICAL DEVICE BATTERY REPLACEMENT 3 0.0222
12 PATIENT ELOPEMENT 8 0.0219
13 SOFT TISSUE MASS 10 0.0216
14 PARKINSONIAN REST TREMOR 4 0.0212
15 CONFUSIONAL AROUSAL 3 0.0186
16 MESENTERIC ARTERY THROMBOSIS 7 0.0182
17 STOMA SITE DISCOMFORT 4 0.0176
18 CATHETER SITE DISCOLOURATION 2 0.0164
19 DOPAMINE DYSREGULATION SYNDROME 6 0.0135
20 SEASONAL AFFECTIVE DISORDER 4 0.0126
21 NEURODEGENERATIVE DISORDER 7 0.0113
22 DELUSION OF GRANDEUR 5 0.0111
23 PARKINSON'S DISEASE 27 0.0106
24 HAEMANGIOMA OF BONE 2 0.0105
25 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 4 0.0100
26 DEEP BRAIN STIMULATION 6 0.0099
27 ANTICHOLINERGIC SYNDROME 15 0.0094
28 HEAT ILLNESS 6 0.0089
29 ENTERAL NUTRITION 5 0.0086
30 MULTIPLE SYSTEM ATROPHY 3 0.0085
31 LIPIDS ABNORMAL 6 0.0083
32 SUBILEUS 17 0.0082
33 STOMA SITE HYPERGRANULATION 5 0.0079
34 REDUCED FACIAL EXPRESSION 8 0.0079
35 ON AND OFF PHENOMENON 43 0.0077
36 MEDICAL DEVICE CHANGE 4 0.0075
37 STOMA SITE IRRITATION 4 0.0074
38 DEMENTIA WITH LEWY BODIES 8 0.0072
39 MEDICAL DEVICE SITE PAIN 4 0.0071
40 REFLUX LARYNGITIS 3 0.0068
41 FREEZING PHENOMENON 24 0.0065
42 STREPTOCOCCAL BACTERAEMIA 7 0.0064
43 EUTHANASIA 2 0.0063
44 INTERMITTENT CLAUDICATION 10 0.0063
45 DUPLICATE THERAPY ERROR 2 0.0062
46 DREAMY STATE 2 0.0062
47 ILLUSION 10 0.0060
48 COMMINUTED FRACTURE 2 0.0060
49 STOMA SITE DISCHARGE 16 0.0058
50 ORTHOSTATIC INTOLERANCE 4 0.0056
51 HALLUCINATION, VISUAL 117 0.0055
52 PRESBYOPIA 3 0.0054
53 STOMA SITE INFECTION 7 0.0054
54 BONE FRAGMENTATION 3 0.0054
55 STOMA SITE ERYTHEMA 10 0.0053
56 STOMA SITE HAEMORRHAGE 8 0.0052
57 CARDIAC DEATH 6 0.0050
58 DELUSIONAL PERCEPTION 2 0.0048
59 PARKINSONIAN GAIT 3 0.0048
60 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 5 0.0047
61 RESTING TREMOR 3 0.0046
62 CHOREA 8 0.0046
63 NONSPECIFIC REACTION 25 0.0046
64 COMPULSIONS 3 0.0045
65 STOMA SITE REACTION 3 0.0044
66 FIBROMA 4 0.0044
67 DELUSION 65 0.0042
68 INFUSION SITE NODULE 4 0.0042
69 HALLUCINATION 306 0.0041
70 STOMA SITE INFLAMMATION 3 0.0040
71 CREATINE KINASE INCREASED 3 0.0039
72 AORTIC DISORDER 3 0.0038
73 HYPERMETABOLISM 2 0.0038
74 YAWNING 10 0.0037
75 BLEEDING VARICOSE VEIN 2 0.0037
76 VERTEBRAL FORAMINAL STENOSIS 3 0.0036
77 ABDOMINAL TENDERNESS 18 0.0036
78 PATHOLOGICAL GAMBLING 6 0.0036
79 BRAIN SCAN ABNORMAL 2 0.0036
80 GAZE PALSY 6 0.0035
81 ADENOMA BENIGN 3 0.0035
82 DISTRACTIBILITY 4 0.0035
83 FAECALOMA 19 0.0035
84 ACUTE PRERENAL FAILURE 4 0.0035
85 AORTIC CALCIFICATION 2 0.0034
86 GASTROINTESTINAL SOUNDS ABNORMAL 17 0.0034
87 AUTONOMIC NERVOUS SYSTEM IMBALANCE 10 0.0034
88 STOMA SITE PAIN 5 0.0034
89 AMBLYOPIA 2 0.0034
90 ABDOMINAL NEOPLASM 3 0.0034
91 BONE CYST 3 0.0032
92 BLADDER CATHETERISATION 3 0.0031
93 BRADYKINESIA 18 0.0030
94 HALLUCINATION, TACTILE 2 0.0030
95 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 3 0.0030
96 STOMA COMPLICATION 3 0.0030
97 CHOREOATHETOSIS 2 0.0029
98 CAROTID ARTERIOSCLEROSIS 3 0.0029
99 LANGUAGE DISORDER 6 0.0028
100 AORTIC VALVE SCLEROSIS 2 0.0027
101 PARESIS 6 0.0027
102 MUSCLE RIGIDITY 32 0.0027
103 CATHETER SITE DISCHARGE 3 0.0027
104 CATHETER SITE RELATED REACTION 2 0.0027
105 DRUG EFFECT VARIABLE 3 0.0026
106 PRODUCT RESIDUE PRESENT 14 0.0026
107 DEMENTIA 70 0.0025
108 CHOROIDAL EFFUSION 2 0.0025
109 PARKINSONISM 24 0.0025
110 DYSKINESIA 100 0.0025
111 BREAST OPERATION 2 0.0024
112 COMPULSIVE SHOPPING 5 0.0024
113 IMPULSE-CONTROL DISORDER 5 0.0024
114 ILEUS 30 0.0024
115 ADRENAL MASS 2 0.0024
116 PERSECUTORY DELUSION 6 0.0024
117 HALLUCINATIONS, MIXED 10 0.0024
118 EYE CONTUSION 5 0.0024
119 CAROTID ARTERY DISEASE 3 0.0024
120 HYPERKINESIA 5 0.0024
121 TORTICOLLIS 5 0.0024
122 LEFT ATRIAL DILATATION 3 0.0024
123 CYSTOCELE 2 0.0023
124 HYPERSEXUALITY 4 0.0022
125 CERUMEN IMPACTION 2 0.0022
126 BONE CONTUSION 2 0.0022
127 ANXIETY DISORDER 7 0.0021
128 STARING 5 0.0021
129 COLON ADENOMA 2 0.0020
130 ACQUIRED HAEMOPHILIA 2 0.0020
131 AORTIC ARTERIOSCLEROSIS 5 0.0019
132 BONE MARROW OEDEMA 2 0.0019
133 BODY TEMPERATURE FLUCTUATION 4 0.0019
134 CONSCIOUSNESS FLUCTUATING 2 0.0019
135 PERSONALITY DISORDER 5 0.0019
136 PELVIC FRACTURE 14 0.0018
137 SENSITIVITY OF TEETH 3 0.0017
138 NEPHROGENIC ANAEMIA 8 0.0017
139 ORTHOSTATIC HYPOTENSION 30 0.0017
140 GAMBLING 2 0.0017
141 KYPHOSIS 3 0.0017
142 NEUROLEPTIC MALIGNANT SYNDROME 20 0.0017
143 DIABETES INSIPIDUS 4 0.0017
144 HYPOKINESIA 24 0.0017
145 WRONG PRODUCT ADMINISTERED 11 0.0016
146 BLADDER DISORDER 16 0.0016
147 FRACTURED SACRUM 2 0.0016
148 EARLY SATIETY 3 0.0015
149 POSTURE ABNORMAL 5 0.0015
150 CARDIOACTIVE DRUG LEVEL INCREASED 2 0.0015
151 CEREBRAL ATROPHY 6 0.0015
152 PRODUCT CLEANING INADEQUATE 4 0.0015
153 DEVICE OCCLUSION 21 0.0015
154 GAMBLING DISORDER 4 0.0015
155 ORAL FUNGAL INFECTION 4 0.0015
156 PSYCHOTIC SYMPTOM 3 0.0015
157 AKINESIA 3 0.0014
158 DISCHARGE 2 0.0014
159 FORMICATION 10 0.0014
160 HIP FRACTURE 46 0.0014
161 CEREBELLAR HAEMORRHAGE 2 0.0014
162 SALIVARY HYPERSECRETION 14 0.0014
163 PRODUCT ADMINISTRATION ERROR 28 0.0014
164 HYPERTONIC BLADDER 4 0.0014
165 DYSPNOEA AT REST 4 0.0014
166 SPINAL OSTEOARTHRITIS 12 0.0014
167 COCCYDYNIA 2 0.0014
168 CALCINOSIS 3 0.0013
169 HAEMORRHAGIC TRANSFORMATION STROKE 2 0.0013
170 FACE INJURY 5 0.0013
171 COMMUNICATION DISORDER 5 0.0013
172 SEROTONIN SYNDROME 24 0.0012
173 HYPERSOMNIA 35 0.0012
174 EXERCISE TOLERANCE DECREASED 7 0.0012
175 DYSGRAPHIA 8 0.0012
176 PRESCRIBED UNDERDOSE 24 0.0012
177 CATHETER SITE HAEMORRHAGE 3 0.0012
178 HYPERPARATHYROIDISM SECONDARY 3 0.0012
179 PERSONALITY CHANGE 11 0.0012
180 HYPERTHERMIA 9 0.0012
181 HEPATIC LESION 5 0.0012
182 CATATONIA 6 0.0011
183 NASAL DISCOMFORT 9 0.0011
184 TRICUSPID VALVE INCOMPETENCE 9 0.0011
185 COMPRESSION FRACTURE 6 0.0011
186 IRON DEFICIENCY 5 0.0011
187 DEVICE ALARM ISSUE 2 0.0011
188 DEVICE KINK 4 0.0011
189 MYOCLONUS 13 0.0011
190 DYSTONIA 21 0.0011
191 LOSS OF CONTROL OF LEGS 4 0.0011
192 ABNORMAL BEHAVIOUR 41 0.0010
193 THERAPEUTIC PRODUCT EFFECT VARIABLE 4 0.0010
194 DYSSTASIA 30 0.0010
195 LUMBAR SPINAL STENOSIS 3 0.0010
196 EYE MOVEMENT DISORDER 7 0.0010
197 CARDIAC DISCOMFORT 2 0.0010
198 REBOUND ACID HYPERSECRETION 3 0.0010
199 RESTLESS LEGS SYNDROME 18 0.0010
200 TENSION 6 0.0010
201 DYSLIPIDAEMIA 5 0.0010
202 AMMONIA INCREASED 5 0.0010
203 GOITRE 4 0.0010
204 INTENTIONAL UNDERDOSE 7 0.0010
205 CONFUSIONAL STATE 154 0.0010
206 LOWER GASTROINTESTINAL HAEMORRHAGE 7 0.0009
207 SCREAMING 6 0.0009
208 AORTIC VALVE INCOMPETENCE 4 0.0009
209 ORAL DISCOMFORT 13 0.0009
210 CATHETER SITE ERYTHEMA 2 0.0009
211 OVERWEIGHT 5 0.0009
212 PARANOIA 16 0.0009
213 GAIT INABILITY 31 0.0009
214 ATRIOVENTRICULAR BLOCK FIRST DEGREE 4 0.0009
215 INFUSION SITE HAEMORRHAGE 3 0.0009
216 COLONOSCOPY 2 0.0009
217 PEPTIC ULCER 3 0.0009
218 CONCUSSION 7 0.0009
219 BLOOD CREATINE INCREASED 4 0.0009
220 GASTRIC ULCER HAEMORRHAGE 5 0.0009
221 LYME DISEASE 3 0.0009
222 THERAPEUTIC AGENT TOXICITY 3 0.0009
223 TERMINAL STATE 6 0.0009
224 SPEECH DISORDER 47 0.0009
225 POTENTIATING DRUG INTERACTION 3 0.0009
226 FEAR OF DEATH 2 0.0009
227 HEAD INJURY 28 0.0009
228 DISORIENTATION 35 0.0009
229 OBSESSIVE-COMPULSIVE DISORDER 7 0.0009
230 DIFFICULTY IN WALKING 3 0.0009
231 CERVICAL VERTEBRAL FRACTURE 3 0.0009
232 ABNORMAL DREAMS 24 0.0009
233 DROOLING 6 0.0009
234 FLAT AFFECT 2 0.0009
235 DECUBITUS ULCER 7 0.0009
236 BILIRUBIN CONJUGATED INCREASED 2 0.0009
237 HYPOVOLAEMIA 5 0.0009
238 INCONTINENCE 9 0.0009
239 SUDDEN DEATH 9 0.0008
240 SPINAL COLUMN STENOSIS 4 0.0008
241 PSYCHOTIC DISORDER 25 0.0008
242 GLOSSITIS 3 0.0008
243 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 8 0.0008
244 DEVICE PLACEMENT ISSUE 3 0.0008
245 FACIAL BONES FRACTURE 3 0.0008
246 BONE LESION 3 0.0008
247 TREMOR 137 0.0008
248 FACIAL PARALYSIS 7 0.0008
249 DERMAL CYST 2 0.0008
250 COGNITIVE DISORDER 38 0.0008
251 SKIN HAEMORRHAGE 12 0.0008
252 URINARY RETENTION 27 0.0008
253 NIGHTMARE 28 0.0008
254 SCOLIOSIS 5 0.0008
255 GASTROINTESTINAL TUBE INSERTION 2 0.0008
256 PRE-EXISTING CONDITION IMPROVED 5 0.0008
257 IMPULSIVE BEHAVIOUR 3 0.0008
258 MENTAL STATUS CHANGES 22 0.0008
259 AGITATION 58 0.0008
260 ENDODONTIC PROCEDURE 2 0.0008
261 ANGLE CLOSURE GLAUCOMA 2 0.0008
262 INITIAL INSOMNIA 8 0.0008
263 BENIGN PROSTATIC HYPERPLASIA 4 0.0008
264 PANIC DISORDER 3 0.0008
265 INCOHERENT 5 0.0008
266 EPIGASTRIC DISCOMFORT 3 0.0008
267 FALL 255 0.0008
268 AFFECTIVE DISORDER 6 0.0008
269 PNEUMONIA ASPIRATION 19 0.0008
270 WALKING AID USER 5 0.0008
271 PRODUCT DISTRIBUTION ISSUE 7 0.0008
272 BLOOD PRESSURE FLUCTUATION 18 0.0007
273 SQUAMOUS CELL CARCINOMA 7 0.0007
274 BLOOD SODIUM INCREASED 2 0.0007
275 BEHAVIOUR DISORDER 4 0.0007
276 BLOOD PRESSURE DECREASED 49 0.0007
277 DEPRESSED LEVEL OF CONSCIOUSNESS 29 0.0007
278 ASPIRATION 8 0.0007
279 MANIA 12 0.0007
280 HYPERKERATOSIS 4 0.0007
281 CHOLECYSTITIS INFECTIVE 2 0.0007
282 BALANCE DISORDER 62 0.0007
283 DIABETIC COMA 2 0.0007
284 ENDOTRACHEAL INTUBATION 2 0.0007
285 RESTLESSNESS 26 0.0007
286 MITRAL VALVE INCOMPETENCE 8 0.0007
287 HAND FRACTURE 5 0.0007
288 LEFT VENTRICULAR HYPERTROPHY 3 0.0007
289 MICTURITION URGENCY 8 0.0007
290 MIDDLE INSOMNIA 13 0.0007
291 HORDEOLUM 3 0.0007
292 SLUGGISHNESS 7 0.0007
293 SENSORY DISTURBANCE 11 0.0007
294 DEVICE POWER SOURCE ISSUE 2 0.0007
295 HAEMORRHAGIC ANAEMIA 3 0.0007
296 DECREASED INTEREST 4 0.0007
297 ENERGY INCREASED 4 0.0007
298 CARDIOTOXICITY 6 0.0007
299 HYPERLIPIDAEMIA 8 0.0007
300 URINARY TRACT DISORDER 3 0.0007
301 GAIT DISTURBANCE 127 0.0007
302 PLATELET COUNT ABNORMAL 4 0.0007
303 DYSCHEZIA 2 0.0007
304 ENCEPHALOPATHY 16 0.0007
305 FAMILY STRESS 2 0.0006
306 YELLOW SKIN 3 0.0006
307 SOMNOLENCE 128 0.0006
308 BLEPHAROSPASM 4 0.0006
309 SPUTUM DISCOLOURED 6 0.0006
310 BILE DUCT STONE 2 0.0006
311 MOOD ALTERED 17 0.0006
312 PRESYNCOPE 15 0.0006
313 FACET JOINT SYNDROME 2 0.0006
314 SOMNAMBULISM 4 0.0006
315 HYPOGAMMAGLOBULINAEMIA 4 0.0006
316 BREATH SOUNDS ABNORMAL 3 0.0006
317 HOSPICE CARE 6 0.0006
318 DIABETIC NEUROPATHY 3 0.0006
319 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
320 PANIC ATTACK 22 0.0006
321 END STAGE RENAL DISEASE 11 0.0006
322 WHITE BLOOD CELL COUNT INCREASED 23 0.0006
323 ECONOMIC PROBLEM 9 0.0006
324 URINARY TRACT INFECTION 100 0.0006
325 BLOOD SODIUM DECREASED 11 0.0006
326 UNRESPONSIVE TO STIMULI 15 0.0006
327 ANURIA 5 0.0006
328 VARICOSE VEIN 3 0.0006
329 FUNCTIONAL GASTROINTESTINAL DISORDER 2 0.0006
330 AORTIC STENOSIS 2 0.0006
331 CAROTID ARTERY STENOSIS 2 0.0006
332 CARPAL TUNNEL SYNDROME 8 0.0006
333 DYSPHAGIA 54 0.0006
334 HANGOVER 2 0.0006
335 EMBOLIC STROKE 2 0.0006
336 HALLUCINATION, AUDITORY 9 0.0006
337 WRONG DRUG ADMINISTERED 5 0.0006
338 FACIAL PAIN 5 0.0006
339 DYSARTHRIA 21 0.0006
340 MEMORY IMPAIRMENT 76 0.0006
341 DEPRESSED MOOD 29 0.0005
342 CAROTID ARTERY OCCLUSION 2 0.0005
343 CUTANEOUS VASCULITIS 2 0.0005
344 GENERALISED TONIC-CLONIC SEIZURE 9 0.0005
345 INCREASED TENDENCY TO BRUISE 5 0.0005
346 PSYCHOMOTOR HYPERACTIVITY 9 0.0005
347 UROSEPSIS 5 0.0005
348 PSYCHIATRIC SYMPTOM 4 0.0005
349 DRUG EFFECT LESS THAN EXPECTED 8 0.0005
350 AGGRESSION 27 0.0005
351 HEART RATE ABNORMAL 3 0.0005
352 CONSTIPATION 117 0.0005
353 THERAPEUTIC RESPONSE UNEXPECTED 24 0.0005
354 RIB FRACTURE 11 0.0005
355 MOBILITY DECREASED 38 0.0005
356 CATHETER SITE INFECTION 2 0.0005
357 PERONEAL NERVE PALSY 3 0.0005
358 CHRONIC KIDNEY DISEASE 40 0.0005
359 NEUROLOGICAL SYMPTOM 3 0.0005
360 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 25 0.0005
361 SYNCOPE 52 0.0005
362 HYPERCHOLESTEROLAEMIA 5 0.0005
363 SINUS BRADYCARDIA 5 0.0005
364 RALES 3 0.0005
365 DIZZINESS POSTURAL 5 0.0005
366 HAEMORRHAGIC STROKE 4 0.0005
367 POOR QUALITY SLEEP 11 0.0005
368 URINE ODOUR ABNORMAL 3 0.0005
369 PERIPHERAL COLDNESS 7 0.0005
370 RENAL TUBULAR NECROSIS 5 0.0005
371 HEAD DISCOMFORT 9 0.0005
372 PRODUCT DOSE OMISSION 33 0.0005
373 RENAL CYST 4 0.0005
374 MUSCULOSKELETAL STIFFNESS 44 0.0005
375 HYPERPHAGIA 2 0.0005
376 BLEPHARITIS 2 0.0005
377 MOVEMENT DISORDER 16 0.0005
378 SLEEP DISORDER 35 0.0005
379 FUNGAL SKIN INFECTION 2 0.0005
380 NOCTURIA 6 0.0005
381 ABNORMAL FAECES 4 0.0005
382 DRUG INTERACTION 76 0.0005
383 TRANSIENT ISCHAEMIC ATTACK 16 0.0005
384 VITAMIN D DECREASED 4 0.0005
385 HAEMOGLOBIN ABNORMAL 3 0.0005
386 DECREASED ACTIVITY 5 0.0005
387 OSTEOPENIA 7 0.0005
388 BONE CANCER 2 0.0005
389 REFUSAL OF TREATMENT BY PATIENT 3 0.0005
390 DIVERTICULUM INTESTINAL 2 0.0005
391 NEUROTOXICITY 8 0.0005
392 DYSPHEMIA 2 0.0005
393 APPETITE DISORDER 3 0.0005
394 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 4 0.0005
395 NERVE INJURY 5 0.0004
396 POST-TRAUMATIC STRESS DISORDER 3 0.0004
397 MALNUTRITION 5 0.0004
398 CONDITION AGGRAVATED 134 0.0004
399 IMPAIRED GASTRIC EMPTYING 6 0.0004
400 URINARY INCONTINENCE 13 0.0004
401 ABDOMINAL HERNIA 2 0.0004
402 DISEASE COMPLICATION 2 0.0004
403 DRUG LEVEL ABOVE THERAPEUTIC 2 0.0004
404 JOINT EFFUSION 3 0.0004
405 DEVICE ISSUE 39 0.0004
406 IRON DEFICIENCY ANAEMIA 4 0.0004
407 INTERVERTEBRAL DISC DEGENERATION 4 0.0004
408 DELIRIUM 15 0.0004
409 POLLAKIURIA 18 0.0004
410 MUSCULAR WEAKNESS 49 0.0004
411 HYPOPHAGIA 11 0.0004
412 ILL-DEFINED DISORDER 26 0.0004
413 DUODENAL ULCER 3 0.0004
414 DIVERTICULUM 3 0.0004
415 WRIST FRACTURE 5 0.0004
416 ACUTE RESPIRATORY FAILURE 8 0.0004
417 IRRITABILITY 25 0.0004
418 PANIC REACTION 3 0.0004
419 GLAUCOMA 8 0.0004
420 TONGUE DISORDER 3 0.0004
421 INJECTION SITE HAEMATOMA 6 0.0004
422 INTERVERTEBRAL DISC PROTRUSION 9 0.0004
423 MAJOR DEPRESSION 3 0.0004
424 CHOKING 8 0.0004
425 CARDIOMEGALY 5 0.0004
426 HEPARIN-INDUCED THROMBOCYTOPENIA 2 0.0004
427 SPINAL OPERATION 5 0.0004
428 TENDON RUPTURE 5 0.0004
429 ARTHROPOD BITE 3 0.0004
430 PRODUCT DOSE OMISSION ISSUE 119 0.0004
431 THERAPEUTIC PRODUCT EFFECT DECREASED 18 0.0004
432 TOOTH EXTRACTION 5 0.0004
433 APHASIA 12 0.0004
434 DIZZINESS 198 0.0004
435 EMPHYSEMA 4 0.0004
436 DRY MOUTH 32 0.0004
437 INSOMNIA 105 0.0004
438 ACIDOSIS 3 0.0004
439 EUPHORIC MOOD 4 0.0004
440 RENAL FAILURE CHRONIC 3 0.0004
441 CACHEXIA 2 0.0004
442 CEREBRAL ISCHAEMIA 2 0.0004
443 FAILURE TO THRIVE 2 0.0004
444 BEDRIDDEN 5 0.0004
445 KNEE ARTHROPLASTY 8 0.0004
446 SCRATCH 4 0.0004
447 PANCREATITIS 20 0.0004
448 JOINT DISLOCATION 4 0.0004
449 RESPIRATORY TRACT CONGESTION 6 0.0004
450 OSTEOARTHRITIS 16 0.0004
451 EATING DISORDER 8 0.0004
452 THINKING ABNORMAL 7 0.0004
453 JOINT INJURY 8 0.0004
454 SENSORY LOSS 3 0.0004
455 FEAR 10 0.0004
456 DISTURBANCE IN ATTENTION 20 0.0004
457 MUSCLE DISORDER 3 0.0004
458 MUSCLE TIGHTNESS 6 0.0004
459 NEURALGIA 9 0.0004
460 FEELING JITTERY 7 0.0004
461 BLOOD POTASSIUM DECREASED 11 0.0004
462 ABASIA 9 0.0004
463 VENTRICULAR TACHYCARDIA 6 0.0004
464 CHOKING SENSATION 2 0.0004
465 STEVENS-JOHNSON SYNDROME 8 0.0004
466 FEELING COLD 10 0.0004
467 NEPHROPATHY TOXIC 4 0.0004
468 BLOOD CALCIUM DECREASED 4 0.0004
469 FEMUR FRACTURE 11 0.0004
470 RENAL FAILURE 47 0.0004
471 ACTIVITIES OF DAILY LIVING IMPAIRED 7 0.0004
472 CHOLECYSTITIS ACUTE 2 0.0004
473 DEHYDRATION 47 0.0004
474 MYOCARDIAL ISCHAEMIA 4 0.0004
475 INTENTIONAL DOSE OMISSION 10 0.0004
476 INTERNAL HAEMORRHAGE 4 0.0003
477 MUSCULOSKELETAL DISCOMFORT 6 0.0003
478 ADVERSE DRUG REACTION 31 0.0003
479 MOOD SWINGS 11 0.0003
480 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 18 0.0003
481 JOINT STIFFNESS 9 0.0003
482 CONTUSION 33 0.0003
483 BLOOD CALCIUM INCREASED 3 0.0003
484 HYPERCHLORHYDRIA 2 0.0003
485 LUNG INFILTRATION 3 0.0003
486 HYPOTENSION 68 0.0003
487 BLOOD IRON DECREASED 4 0.0003
488 CATARACT OPERATION 2 0.0003
489 RENAL INJURY 10 0.0003
490 PULMONARY MASS 5 0.0003
491 CARDIAC PACEMAKER INSERTION 2 0.0003
492 ROAD TRAFFIC ACCIDENT 14 0.0003
493 THROAT IRRITATION 15 0.0003
494 BLOOD PRESSURE INCREASED 51 0.0003
495 ANAL INCONTINENCE 3 0.0003
496 WITHDRAWAL SYNDROME 14 0.0003
497 TOOTHACHE 6 0.0003
498 OSTEOMYELITIS 6 0.0003
499 LOCALISED INFECTION 8 0.0003
500 MENTAL IMPAIRMENT 8 0.0003
501 DEPRESSION 75 0.0003
502 BONE DISORDER 6 0.0003
503 RESPIRATORY FAILURE 24 0.0003
504 EXOSTOSIS 3 0.0003
505 TYPE 2 DIABETES MELLITUS 11 0.0003
506 NERVOUSNESS 17 0.0003
507 NERVE COMPRESSION 3 0.0003
508 ASTHENIA 122 0.0003
509 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 23 0.0003
510 MUSCULOSKELETAL CHEST PAIN 5 0.0003
511 PHARYNGITIS 4 0.0003
512 CYST 4 0.0003
513 NECK PAIN 18 0.0003
514 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 15 0.0003
515 DEFORMITY 3 0.0003
516 BASAL CELL CARCINOMA 5 0.0003
517 BRAIN FOG 5 0.0003
518 ARTERIOSCLEROSIS 3 0.0003
519 BLOOD URINE PRESENT 6 0.0003
520 INJECTION SITE IRRITATION 4 0.0003
521 INJURY 22 0.0003
522 LETHARGY 18 0.0003
523 BLOOD CREATINE PHOSPHOKINASE INCREASED 9 0.0003
524 HYPOXIA 11 0.0003
525 LOSS OF CONSCIOUSNESS 40 0.0003
526 TREATMENT NONCOMPLIANCE 17 0.0003
527 ATELECTASIS 3 0.0003
528 LIVER FUNCTION TEST ABNORMAL 9 0.0003
529 DYSPHONIA 18 0.0003
530 CEREBRAL HAEMORRHAGE 11 0.0003
531 ABDOMINAL DISTENSION 32 0.0003
532 SEDATION 8 0.0003
533 KNEE OPERATION 3 0.0003
534 FEELING ABNORMAL 73 0.0003
535 GENERAL PHYSICAL HEALTH DETERIORATION 35 0.0003
536 BLOOD PRESSURE ABNORMAL 6 0.0003
537 BRADYCARDIA 16 0.0003
538 UPPER LIMB FRACTURE 6 0.0003
539 BRAIN INJURY 3 0.0003
540 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
541 MALIGNANT MELANOMA 4 0.0003
542 BREAST MASS 2 0.0003
543 OEDEMA PERIPHERAL 36 0.0003
544 DEATH 254 0.0003
545 BODY TEMPERATURE INCREASED 6 0.0003
546 COMA 14 0.0003
547 THERAPY INTERRUPTED 21 0.0003
548 BLOOD TESTOSTERONE DECREASED 2 0.0003
549 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 3 0.0003
550 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 5 0.0003
551 ENCEPHALITIS 2 0.0003
552 VENTRICULAR EXTRASYSTOLES 3 0.0003
553 EYE DISCHARGE 3 0.0003
554 DEVICE DEFECTIVE 5 0.0003
555 UNDERDOSE 21 0.0003
556 ACUTE KIDNEY INJURY 44 0.0003
557 APHONIA 4 0.0003
558 FOLLICULITIS 3 0.0003
559 DEVICE USE ISSUE 5 0.0003
560 PERIPHERAL SWELLING 44 0.0003
561 CYSTITIS 9 0.0003
562 HYPOTHYROIDISM 9 0.0003
563 ANXIETY 80 0.0003
564 HYPERHIDROSIS 36 0.0003
565 PARALYSIS 4 0.0003
566 SUBDURAL HAEMATOMA 4 0.0003
567 PHARYNGITIS STREPTOCOCCAL 3 0.0003
568 AMNESIA 18 0.0003
569 ANOSMIA 4 0.0003
570 SKIN LACERATION 3 0.0003
571 COMPLICATION ASSOCIATED WITH DEVICE 4 0.0003
572 CRYING 10 0.0003
573 PULMONARY THROMBOSIS 3 0.0003
574 DENTAL CARIES 3 0.0003
575 FOOT DEFORMITY 3 0.0003
576 PHARMACEUTICAL PRODUCT COMPLAINT 7 0.0003
577 FEELING DRUNK 2 0.0003
578 IMMUNODEFICIENCY 4 0.0003
579 BACTERIAL INFECTION 5 0.0003
580 PULMONARY OEDEMA 12 0.0003
581 ORAL PAIN 6 0.0003
582 HAEMORRHAGE INTRACRANIAL 4 0.0003
583 OSTEOPOROSIS 11 0.0003
584 ANHEDONIA 7 0.0003
585 ANGER 9 0.0003
586 CHROMATURIA 6 0.0003
587 HEART RATE IRREGULAR 6 0.0003
588 DYSPNOEA EXERTIONAL 10 0.0003
589 BLOOD COUNT ABNORMAL 4 0.0003
590 FOOT FRACTURE 5 0.0003
591 PLEURAL EFFUSION 16 0.0003
592 MUSCULOSKELETAL DISORDER 5 0.0003
593 SLEEP APNOEA SYNDROME 5 0.0003
594 BOWEL MOVEMENT IRREGULARITY 2 0.0003
595 FEELING HOT 16 0.0003
596 DISSOCIATION 2 0.0003
597 PULMONARY FIBROSIS 5 0.0003
598 DRY EYE 13 0.0003
599 MUSCLE TWITCHING 6 0.0003
600 LOWER LIMB FRACTURE 5 0.0003
601 FATIGUE 202 0.0003
602 PRESCRIBED OVERDOSE 5 0.0003
603 BLOOD CHOLESTEROL INCREASED 12 0.0003
604 HEART RATE DECREASED 9 0.0003
605 SWOLLEN TONGUE 8 0.0003
606 SPLENOMEGALY 3 0.0003
607 SPINAL PAIN 3 0.0003
608 NAUSEA 202 0.0003
609 PNEUMONIA 82 0.0003
610 THERAPY CESSATION 13 0.0003
611 ATAXIA 3 0.0003
612 BACTERAEMIA 3 0.0003
613 CHOLECYSTITIS 3 0.0003
614 GINGIVAL PAIN 2 0.0003
615 CARDIAC FAILURE CONGESTIVE 20 0.0002
616 FRUSTRATION TOLERANCE DECREASED 2 0.0002
617 BURSITIS 3 0.0002
618 BLOOD POTASSIUM INCREASED 4 0.0002
619 BACK DISORDER 4 0.0002
620 RED BLOOD CELL COUNT DECREASED 7 0.0002
621 ABDOMINAL DISCOMFORT 41 0.0002
622 ANGINA PECTORIS 7 0.0002
623 METASTASES TO BONE 4 0.0002
624 BRONCHITIS 18 0.0002
625 PULMONARY EMBOLISM 23 0.0002
626 THERAPEUTIC RESPONSE SHORTENED 8 0.0002
627 HAIR COLOUR CHANGES 3 0.0002
628 AGEUSIA 6 0.0002
629 GASTROINTESTINAL HAEMORRHAGE 20 0.0002
630 BLOOD UREA INCREASED 4 0.0002
631 POISONING 3 0.0002
632 COLITIS 9 0.0002
633 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 13 0.0002
634 DECREASED APPETITE 55 0.0002
635 MUSCLE ATROPHY 3 0.0002
636 ATRIAL FIBRILLATION 23 0.0002
637 HEMIPARESIS 4 0.0002
638 SWELLING 22 0.0002
639 VISUAL IMPAIRMENT 29 0.0002
640 ROTATOR CUFF SYNDROME 3 0.0002
641 SKIN ULCER 6 0.0002
642 BLOOD MAGNESIUM DECREASED 2 0.0002
643 LACRIMATION INCREASED 7 0.0002
644 HIATUS HERNIA 3 0.0002
645 CORONARY ARTERY DISEASE 7 0.0002
646 DIPLOPIA 6 0.0002
647 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
648 PRODUCTIVE COUGH 11 0.0002
649 LOCAL SWELLING 4 0.0002
650 INCORRECT DOSE ADMINISTERED BY DEVICE 6 0.0002
651 GASTRITIS 6 0.0002
652 GROIN PAIN 2 0.0002
653 PULMONARY CONGESTION 3 0.0002
654 GRIP STRENGTH DECREASED 2 0.0002
655 SARS-COV-2 TEST POSITIVE 3 0.0002
656 ADVERSE REACTION 3 0.0002
657 DIABETES MELLITUS INADEQUATE CONTROL 4 0.0002
658 UNEVALUABLE EVENT 17 0.0002
659 QUALITY OF LIFE DECREASED 3 0.0002
660 MUSCLE SPASMS 41 0.0002
661 GASTROINTESTINAL INFECTION 2 0.0002
662 FREQUENT BOWEL MOVEMENTS 6 0.0002
663 SINUS CONGESTION 3 0.0002
664 PALPITATIONS 26 0.0002
665 DRUG INEFFECTIVE 292 0.0002
666 VOMITING 104 0.0002
667 NEUROPATHY PERIPHERAL 21 0.0002
668 HYPOAESTHESIA 33 0.0002
669 AKATHISIA 3 0.0002
670 GINGIVAL BLEEDING 3 0.0002
671 CEREBROVASCULAR ACCIDENT 37 0.0002
672 PROSTATIC SPECIFIC ANTIGEN INCREASED 3 0.0002
673 COUGH 61 0.0002
674 HYPERTENSION 46 0.0002
675 ADVERSE EVENT 20 0.0002
676 RHABDOMYOLYSIS 9 0.0002
677 HYPOMAGNESAEMIA 3 0.0002
678 COORDINATION ABNORMAL 3 0.0002
679 HEPATIC STEATOSIS 4 0.0002
680 MASS 3 0.0002
681 HEPATIC ENCEPHALOPATHY 2 0.0002
682 STAPHYLOCOCCAL INFECTION 7 0.0002
683 SEASONAL ALLERGY 3 0.0002
684 PRODUCT DOSE OMISSION IN ERROR 6 0.0002
685 PAIN IN JAW 6 0.0002
686 HEPATOCELLULAR INJURY 3 0.0002
687 PROTEINURIA 4 0.0002
688 VIRAL INFECTION 7 0.0002
689 PRODUCT PRESCRIBING ERROR 5 0.0002
690 HYPOACUSIS 9 0.0002
691 POST PROCEDURAL COMPLICATION 4 0.0002
692 AFFECT LABILITY 2 0.0002
693 WEIGHT DECREASED 58 0.0002
694 TOXICITY TO VARIOUS AGENTS 35 0.0002
695 DEVICE LEAKAGE 9 0.0002
696 DEVICE DISLOCATION 9 0.0002
697 APATHY 3 0.0002
698 GASTROENTERITIS 3 0.0002
699 HAEMORRHOIDS 4 0.0002
700 LUNG DISORDER 10 0.0002
701 HEPATOMEGALY 2 0.0002
702 CARDIAC DISORDER 19 0.0002
703 EMBEDDED DEVICE 2 0.0002
704 HAEMATOCRIT DECREASED 4 0.0002
705 COLON CANCER 3 0.0002
706 RHINORRHOEA 13 0.0002
707 THERAPY NON-RESPONDER 9 0.0002
708 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 36 0.0002
709 SPINAL FRACTURE 4 0.0002
710 SEIZURE 23 0.0002
711 GASTROOESOPHAGEAL REFLUX DISEASE 16 0.0002
712 PRODUCT PHYSICAL ISSUE 4 0.0002
713 BACK PAIN 46 0.0002
714 MEDICATION ERROR 11 0.0002
715 TASTE DISORDER 4 0.0002
716 BLINDNESS 8 0.0002
717 PRODUCT ADHESION ISSUE 7 0.0002
718 HIP ARTHROPLASTY 3 0.0002
719 DRUG ADMINISTRATION ERROR 6 0.0002
720 EAR DISCOMFORT 2 0.0002
721 THYROID DISORDER 3 0.0002
722 EMOTIONAL DISORDER 6 0.0002
723 FLATULENCE 11 0.0002
724 CARDIAC ARREST 16 0.0002
725 PAIN IN EXTREMITY 57 0.0002
726 DYSPEPSIA 19 0.0002
727 HYPERBILIRUBINAEMIA 2 0.0002
728 HAEMATOMA 5 0.0002
729 TOOTH LOSS 4 0.0002
730 PULMONARY HYPERTENSION 4 0.0002
731 DEAFNESS 5 0.0002
732 MOUTH ULCERATION 4 0.0002
733 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
734 PNEUMOTHORAX 3 0.0002
735 SEPSIS 21 0.0002
736 BODY HEIGHT DECREASED 2 0.0002
737 CARDIAC FAILURE 15 0.0002
738 BREAST CANCER METASTATIC 2 0.0002
739 DRUG EFFECT DECREASED 10 0.0002
740 ABDOMINAL PAIN 43 0.0002
741 BACK INJURY 2 0.0002
742 PALLOR 5 0.0002
743 PRODUCT DISPENSING ERROR 4 0.0002
744 MYOCARDIAL INFARCTION 32 0.0002
745 RESPIRATORY ARREST 5 0.0002
746 RESPIRATORY DISTRESS 5 0.0002
747 EXPIRED PRODUCT ADMINISTERED 6 0.0002
748 DISCOMFORT 11 0.0002
749 COAGULOPATHY 3 0.0002
750 TOOTH DISORDER 4 0.0002
751 HYPERTENSIVE CRISIS 2 0.0002
752 ABDOMINAL PAIN UPPER 37 0.0002
753 PLASMA CELL MYELOMA 7 0.0002
754 RENAL IMPAIRMENT 15 0.0002
755 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
756 ANAEMIA 34 0.0002
757 BLISTER 10 0.0002
758 PANCREATITIS ACUTE 4 0.0002
759 FISTULA 2 0.0002
760 CANDIDA INFECTION 3 0.0002
761 HYPONATRAEMIA 10 0.0002
762 DISEASE PROGRESSION 21 0.0002
763 TARDIVE DYSKINESIA 5 0.0002
764 EYE INFECTION 2 0.0002
765 FLUID RETENTION 9 0.0002
766 DRUG INTOLERANCE 17 0.0002
767 PRODUCT AVAILABILITY ISSUE 4 0.0002
768 PRODUCT USE ISSUE 33 0.0002
769 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
770 HAEMATURIA 6 0.0002
771 GASTRIC DISORDER 6 0.0002
772 SKIN DISCOLOURATION 8 0.0002
773 EPISTAXIS 13 0.0002
774 MULTI-ORGAN FAILURE 3 0.0002
775 PRODUCT USE IN UNAPPROVED INDICATION 43 0.0002
776 HYPOKALAEMIA 8 0.0002
777 MALAISE 76 0.0002
778 HOT FLUSH 13 0.0002
779 BONE PAIN 10 0.0002
780 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
781 LYMPHADENOPATHY 6 0.0002
782 DRUG DOSE OMISSION 28 0.0002
783 HOSPITALISATION 26 0.0002
784 NASOPHARYNGITIS 31 0.0002
785 ISCHAEMIC STROKE 3 0.0002
786 CATARACT 10 0.0002
787 BLOOD GLUCOSE DECREASED 8 0.0002
788 HAEMOGLOBIN DECREASED 17 0.0002
789 CONTRAINDICATED PRODUCT ADMINISTERED 5 0.0002
790 RENAL FAILURE ACUTE 7 0.0002
791 HYPERCALCAEMIA 2 0.0002
792 CHEST PAIN 30 0.0002
793 ARTHROPATHY 9 0.0002
794 CONJUNCTIVITIS 3 0.0002
795 OSTEONECROSIS OF JAW 4 0.0002
796 LIMB DISCOMFORT 5 0.0002
797 GENERALISED OEDEMA 2 0.0002
798 DYSGEUSIA 12 0.0002
799 SEPTIC SHOCK 7 0.0002
800 INTESTINAL OBSTRUCTION 6 0.0002
801 BRAIN OEDEMA 2 0.0002
802 INCORRECT DOSE ADMINISTERED 36 0.0002
803 DIABETES MELLITUS 12 0.0002
804 GASTROINTESTINAL DISORDER 14 0.0002
805 DYSPNOEA 88 0.0002
806 SURGERY 9 0.0002
807 ECZEMA 8 0.0002
808 APPLICATION SITE ERYTHEMA 4 0.0002
809 CHOLELITHIASIS 5 0.0002
810 THROMBOCYTOPENIA 17 0.0002
811 WEIGHT INCREASED 34 0.0002
812 DISABILITY 3 0.0002
813 SINUS DISORDER 3 0.0002
814 EAR INFECTION 4 0.0002
815 RENAL DISORDER 7 0.0002
816 LIP SWELLING 5 0.0001
817 EYE HAEMORRHAGE 2 0.0001
818 THROMBOSIS 12 0.0001
819 INTENTIONAL SELF-INJURY 3 0.0001
820 COVID-19 26 0.0001
821 FEEDING DISORDER 3 0.0001
822 THROAT TIGHTNESS 4 0.0001
823 DEVICE BREAKAGE 6 0.0001
824 OCULAR HYPERAEMIA 7 0.0001
825 MULTIPLE SCLEROSIS 7 0.0001
826 DEVICE DELIVERY SYSTEM ISSUE 4 0.0001
827 CORONARY ARTERY OCCLUSION 2 0.0001
828 VISION BLURRED 20 0.0001
829 APPLICATION SITE RASH 2 0.0001
830 INFECTION 21 0.0001
831 DIVERTICULITIS 4 0.0001
832 OVERDOSE 31 0.0001
833 DERMATITIS 3 0.0001
834 HYPERKALAEMIA 5 0.0001
835 BLOOD TEST ABNORMAL 2 0.0001
836 SUICIDAL IDEATION 13 0.0001
837 PAIN 87 0.0001
838 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 10 0.0001
839 RECTAL HAEMORRHAGE 6 0.0001
840 CARDIOGENIC SHOCK 2 0.0001
841 ELECTROCARDIOGRAM QT PROLONGED 5 0.0001
842 ACCIDENTAL UNDERDOSE 2 0.0001
843 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 28 0.0001
844 MENTAL DISORDER 6 0.0001
845 PRODUCT PRESCRIBING ISSUE 3 0.0001
846 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
847 FLUID OVERLOAD 2 0.0001
848 INTENTIONAL PRODUCT MISUSE 12 0.0001
849 DRUG WITHDRAWAL SYNDROME 12 0.0001
850 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
851 NASAL CONGESTION 8 0.0001
852 ASCITES 4 0.0001
853 DYSURIA 5 0.0001
854 LABORATORY TEST ABNORMAL 4 0.0001
855 WHEEZING 8 0.0001
856 GLOSSODYNIA 3 0.0001
857 MUSCULOSKELETAL PAIN 7 0.0001
858 PARAESTHESIA 21 0.0001
859 HEADACHE 83 0.0001
860 APPLICATION SITE PRURITUS 3 0.0001
861 DEVICE FAILURE 2 0.0001
862 NEPHROLITHIASIS 6 0.0001
863 TINNITUS 6 0.0001
864 DEVICE RELATED INFECTION 2 0.0001
865 ANKLE FRACTURE 2 0.0001
866 RASH PRURITIC 7 0.0001
867 BURNING SENSATION 9 0.0001
868 ACUTE MYELOID LEUKAEMIA 2 0.0001
869 CHILLS 15 0.0001
870 CHEST DISCOMFORT 13 0.0001
871 ABSCESS 2 0.0001
872 METABOLIC ACIDOSIS 4 0.0001
873 INTENTIONAL OVERDOSE 8 0.0001
874 EYE PAIN 7 0.0001
875 INTERSTITIAL LUNG DISEASE 6 0.0001
876 TACHYCARDIA 11 0.0001
877 ARTHRALGIA 51 0.0001
878 IMPAIRED HEALING 4 0.0001
879 DEVICE DIFFICULT TO USE 8 0.0001
880 EXTRAPYRAMIDAL DISORDER 3 0.0001
881 CARDIO-RESPIRATORY ARREST 5 0.0001
882 FLUSHING 12 0.0001
883 SINUSITIS 12 0.0001
884 ILLNESS 12 0.0001
885 INFLAMMATION 6 0.0001
886 JOINT SWELLING 14 0.0001
887 STOMATITIS 7 0.0001
888 RESPIRATORY TRACT INFECTION 3 0.0001
889 VERTIGO 7 0.0001
890 DIARRHOEA 74 0.0001
891 ARTHRITIS 9 0.0001
892 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
893 ASPARTATE AMINOTRANSFERASE INCREASED 6 0.0001
894 MYALGIA 19 0.0001
895 JAUNDICE 3 0.0001
896 GOUT 2 0.0001
897 SKIN LESION 3 0.0001
898 ACCIDENTAL OVERDOSE 4 0.0001
899 OFF LABEL USE 95 0.0001
900 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
901 OROPHARYNGEAL PAIN 10 0.0001
902 EYE SWELLING 4 0.0001
903 ERYTHEMA 22 0.0001
904 HEPATIC CIRRHOSIS 2 0.0001
905 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
906 FRACTURE 2 0.0001
907 ARRHYTHMIA 5 0.0001
908 GASTRIC ULCER 2 0.0001
909 DISEASE RECURRENCE 5 0.0001
910 MIGRAINE 10 0.0001
911 RASH ERYTHEMATOUS 5 0.0001
912 HERPES ZOSTER 6 0.0001
913 INJECTION SITE SWELLING 8 0.0001
914 EYE IRRITATION 6 0.0001
915 RASH 45 0.0001
916 EAR PAIN 2 0.0001
917 INTENTIONAL PRODUCT USE ISSUE 9 0.0001
918 ACUTE MYOCARDIAL INFARCTION 3 0.0001
919 PRURITUS 39 0.0001
920 INJECTION SITE HAEMORRHAGE 8 0.0001
921 HEPATIC FAILURE 3 0.0001
922 ALANINE AMINOTRANSFERASE INCREASED 6 0.0001
923 ALOPECIA 19 0.0001
924 HAEMORRHAGE 10 0.0001
925 URTICARIA 16 0.0001
926 PYREXIA 33 0.0001
927 WHITE BLOOD CELL COUNT DECREASED 10 0.0001
928 FAECES DISCOLOURED 2 0.0001
929 OSTEONECROSIS 3 0.0001
930 EYE DISORDER 3 0.0001
931 ANAPHYLACTIC REACTION 5 0.0001
932 BLOOD GLUCOSE INCREASED 17 0.0001
933 FUNGAL INFECTION 3 0.0001
934 SKIN DISORDER 3 0.0001
935 HEPATOTOXICITY 2 0.0001
936 INFLUENZA 10 0.0001
937 OXYGEN SATURATION DECREASED 5 0.0001
938 CONVULSION 5 0.0001
939 RASH MACULAR 3 0.0001
940 TREATMENT FAILURE 7 0.0001
941 PSORIASIS 11 0.0001
942 EMOTIONAL DISTRESS 10 0.0001
943 DRUG EFFECT INCOMPLETE 3 0.0001
944 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
945 THERAPEUTIC RESPONSE DECREASED 5 0.0001
946 SUICIDE ATTEMPT 5 0.0001
947 PRODUCT QUALITY ISSUE 11 0.0001
948 HEART RATE INCREASED 8 0.0001
949 ASTHMA 9 0.0001
950 CELLULITIS 4 0.0001
951 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
952 HAEMATEMESIS 2 0.0001
953 NO ADVERSE EVENT 14 0.0001
954 BLOOD CREATININE INCREASED 5 0.0001
955 DRY SKIN 10 0.0001
956 OEDEMA 4 0.0001
957 LUNG NEOPLASM MALIGNANT 3 0.0001
958 INFLUENZA LIKE ILLNESS 6 0.0001
959 HAEMATOCHEZIA 4 0.0001
960 DRUG ABUSE 6 0.0001
961 HAEMOPTYSIS 2 0.0001
962 DEVICE MALFUNCTION 5 0.0001
963 HYPERSENSITIVITY 13 0.0001
964 PRODUCT STORAGE ERROR 6 0.0001
965 MALIGNANT NEOPLASM PROGRESSION 7 0.0001
966 SKIN IRRITATION 3 0.0001
967 BONE DENSITY DECREASED 2 0.0001
968 HYPOGLYCAEMIA 3 0.0001
969 SWELLING FACE 4 0.0001
970 LEUKOPENIA 3 0.0001
971 NEOPLASM MALIGNANT 4 0.0001
972 INJECTION SITE PRURITUS 4 0.0001
973 SKIN EXFOLIATION 5 0.0001
974 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
975 DEVICE USE ERROR 2 0.0001
976 DERMATITIS ATOPIC 3 0.0001
977 PLATELET COUNT DECREASED 6 0.0001
978 HEPATIC FUNCTION ABNORMAL 2 0.0001
979 PRODUCT SUBSTITUTION ISSUE 3 0.0001
980 NEUTROPENIA 7 0.0001
981 PROSTATE CANCER 4 0.0000
982 INJECTION SITE ERYTHEMA 6 0.0000
983 DEEP VEIN THROMBOSIS 3 0.0000
984 FEBRILE NEUTROPENIA 3 0.0000
985 COLITIS ULCERATIVE 2 0.0000
986 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
987 BREAST CANCER 3 0.0000
988 HEPATIC ENZYME INCREASED 2 0.0000
989 ACNE 2 0.0000
990 DRUG DEPENDENCE 4 0.0000
991 INJECTION SITE PAIN 7 0.0000
992 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000